Efficacy and Safety of a Dietary Supplement Containing a Lipid Co-Extract from Serenoa Repens and Pygeum Africanum for the Treatment of Androgenetic Alopecia in Women: Results of a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
April 2016
in “
Más dermatología
”
TLDR The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.
In 2016, a double-blind, placebo-controlled clinical trial was conducted on 40 post-menopausal women with androgenetic alopecia (AGA) to test the efficacy of a dietary supplement containing a lipid co-extract from Serenoa repens and Pygeum africanum (RJ-SP4AGA). After 16 weeks of treatment, the study found a significant increase in anagen hair (active growth phase) and a decrease in telogen hair (rest phase) in the group treated with RJ-SP4AGA capsules, compared to the placebo group (p<0.001). Hair resistance to traction also increased in both groups after 8 and 16 weeks. The supplement was well tolerated, with only mild digestive adverse events reported. The study concluded that the RJ-SP4AGA supplement could be an effective treatment for AGA in post-menopausal women.
